Replication of ketamine's antidepressant efficacy in bipolar depression: A randomized controlled add-on trial

Biological Psychiatry

Volumn 71, Issue 11, 2012, Pages 939-946

  Zarate Jr , Carlos A ^a   Brutsche, Nancy E ^a   Ibrahim, Lobna ^a   Franco Chaves, Jose ^a   Diazgranados, Nancy ^a   Cravchik, Anibal ^a   Selter, Jessica ^a   Marquardt, Craig A ^a   Liberty, Victoria ^a   Luckenbaugh, David A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antidepressant; bipolar disorder; depression; glutamate; ketamine; NMDA; suicidal ideation

Indexed keywords

KETAMINE; LITHIUM; PLACEBO; VALPROIC ACID;

ADD ON THERAPY; ADULT; AGED; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; AROUSAL; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BLURRED VISION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISSOCIATIVE DISORDER; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DSM-IV; FAINTNESS; FEAR; FEMALE; FLATULENCE; HUMAN; LETHARGY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SEDATION; SENSORY DYSFUNCTION; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP DISORDER; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; BIPOLAR DISORDER; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; SUICIDAL IDEATION; TREATMENT OUTCOME;

EID: 84861099072     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.12.010     Document Type: Article

References (43)

1. M.K. Nock, I. Hwang, N. Sampson, R.C. Kessler, M. Angermeyer, A. Beautrais Cross-national analysis of the associations among mental disorders and suicidal behavior: Findings from the WHO World Mental Health Surveys PLoS Med 6 2009 e1000123
2. M. Nordentoft, P.B. Mortensen, C.B. Pedersen Absolute risk of suicide after first hospital contact in mental disorder Arch Gen Psychiatry 68 2011 1058 1064
3. R.M. Post, G.S. Leverich, L.L. Altshuler, M.A. Frye, T. Suppes, P.E. Keck Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany Int Clin Psychopharmacol 26 2011 96 106
4. N. Diazgranados, L. Ibrahim, N.E. Brutsche, A. Newberg, P. Kronstein, S. Khalife A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Arch Gen Psychiatry 67 2010 793 802
5. R. Machado-Vieira, G. Salvadore, D.A. Luckenbaugh, H.K. Manji, C.A. Zarate Jr Rapid onset of antidepressant action: A new paradigm in the research and treatment of major depressive disorder J Clin Psychiatry 69 2008 946 958 (Pubitemid 351944948)
6. G. Sanacora, C.A. Zarate, J.H. Krystal, H.K. Manji Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Nat Rev Drug Discov 7 2008 426 437 (Pubitemid 351619114)
7. R.E. McCullumsmith, L.V. Kristiansen, M. Beneyto, E. Scarr, B. Dean, J.H. Meador-Woodruff Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder Brain Res 1127 2007 108 118 (Pubitemid 44854837)
8. S.M. Clinton, J.H. Meador-Woodruff Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder Neuropsychopharmacology 29 2004 1353 1362 (Pubitemid 38780658)
9. C. Toro, J.F. Deakin NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder Schizophr Res 80 2005 323 330 (Pubitemid 41713658)
10. M. Itokawa, K. Yamada, Y. Iwayama-Shigeno, Y. Ishitsuka, S. Detera-Wadleigh, T. Yoshikawa Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans Neurosci Lett 345 2003 53 56 (Pubitemid 36694848)
11. L. Martucci, A.H. Wong, V. De Luca, O. Likhodi, G.W. Wong, N. King, J.L. Kennedy N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels Schizophr Res 84 2006 214 221
12. E. Mundo, S. Tharmalingham, M. Neves-Pereira, E.J. Dalton, F. Macciardi, S.V. Parikh Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder Mol Psychiatry 8 2003 241 245 (Pubitemid 36315234)
13. A. Szczepankiewicz, M. Skibinska, A. Suwalska, J. Hauser, J.K. Rybakowski No association of three GRIN2B polymorphisms with lithium response in bipolar patients Pharmacol Rep 61 2009 448 452
14. G. Laje, S. Paddock, H.K. Manji, A.J. Rush, A.F. Wilson, D.S. Charney, F.J. McMahon Genetic markers of suicidal ideation emerging during citalopram treatment of major depression Am J Psychiatry 164 2007 1530 1538 (Pubitemid 350069732)
15. A. Menke, S. Lucae, S. Kloiber, S. Horstmann, T. Bettecken, M. Uhr Genetic markers within glutamate receptors associated with antidepressant treatment-emergent suicidal ideation Am J Psychiatry 165 2008 917 918 (Pubitemid 351948730)
16. G. Nowak, G.A. Ordway, I.A. Paul Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims Brain Res 675 1995 157 164
17. S. Holemans, F. De Paermentier, R.W. Horton, M.R. Crompton, C.L. Katona, J.M. Maloteaux NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides Brain Res 616 1993 138 143 (Pubitemid 23200040)
18. L. Aguado, A. San Antonio, L. Perez, R. del Valle, J. Gomez Effects of the NMDA receptor antagonist ketamine on flavor memory: Conditioned aversion, latent inhibition, and habituation of neophobia Behav Neural Biol 61 1994 271 281
19. L.S. Garcia, C.M. Comim, S.S. Valvassori, G.Z. Reus, L.M. Barbosa, A.C. Andreazza Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus Prog Neuropsychopharmacol Biol Psychiatry 32 2008 140 144
20. S. Maeng, C.A. Zarate Jr, J. Du, R.J. Schloesser, J. McCammon, G. Chen, H.K. Manji Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors Biol Psychiatry 63 2008 349 352 (Pubitemid 351146651)
21. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, M. Iwata mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
22. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, P.F. Cheng NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 2011 91 95
23. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 2000 351 354 (Pubitemid 30109248)
24. C.A. Zarate Jr, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, D.A. Luckenbaugh A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864 (Pubitemid 44188478)
25. M. aan het Rot, K.A. Collins, J.W. Murrough, A.M. Perez, D.L. Reich, D. Charney, S.J. Mathew Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression Biol Psychiatry 67 2010 139 145
26. L.E. Phelps, N. Brutsche, J.R. Moral, D.A. Luckenbaugh, H.K. Manji, C.A. Zarate Jr Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist Biol Psychiatry 65 2009 181 184
27. G.W. Valentine, G.F. Mason, R. Gomez, M. Fasula, J. Watzl, B. Pittman The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS Psychiatry Res 191 2011 122 127
28. B.G. Bunney, W.E. Bunney Rapid-acting antidepressant strategies: Mechanisms of action [published online ahead of print July 7] Int J Neuropsychopharmacol 2011
29. N. Diazgranados, L.A. Ibrahim, N.E. Brutsche, R. Ameli, I.D. Henter, D.A. Luckenbaugh Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder J Clin Psychiatry 71 2010 1605 1611
30. R.B. Price, M.K. Nock, D. Charney, S.J. Mathew Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression Biol Psychiatry 66 2009 522 529
31. G.L. Larkin, A.L. Beautrais A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department Int J Neuropsychopharmacol 14 2011 1127 1131
32. M.B. First, R.L. Spitzer, M. Gibbon, A.R. Williams Structured Clinical Interview for DSM-IV TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2001 New York State Psychiatric Institute, Biometrics Research New York
33. H.A. Sackeim The definition and meaning of treatment-resistant depression J Clin Psychiatry 62 suppl 16 2001 10 17
34. M. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
35. A.T. Beck, A. Beamesderfer Assessment of depression: The depression inventory Mod Probl Pharmacopsychiatry 7 1974 151 169
36. R.C. Aitken Measurement of feelings using visual analogue scales Proc R Soc Med 62 1969 989 993
37. M. Hamilton The assessment of anxiety states by rating Br J Med Psychol 32 1959 50 55
38. J.E. Overall, D.R. Gorham The Brief Psychiatric Rating Scale Psychol Rep 10 1962 799 812
39. J.D. Bremner, J.H. Krystal, F.W. Putnam, S.M. Southwick, C. Marmar, D.S. Charney, C.M. Mazure Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS) J Trauma Stress 11 1998 125 136 (Pubitemid 28097797)
40. R.C. Young, J.T. Biggs, V.E. Ziegler, D.A. Meyer A rating scale for mania: Reliability, validity and sensitivity Br J Psychiatry 133 1978 429 435 (Pubitemid 9006756)
41. I. Pacchiarotti, L. Mazzarini, F. Colom, J. Sanchez-Moreno, P. Girardi, G.D. Kotzalidis, E. Vieta Treatment-resistant bipolar depression: Towards a new definition Acta Psychiatr Scand 120 2009 429 440
42. A. Anand, D.S. Charney, D.A. Oren, R.M. Berman, X.S. Hu, A. Cappiello, J.H. Krystal Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists Arch Gen Psychiatry 57 2000 270 276 (Pubitemid 30140436)
43. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214 (Pubitemid 24081509)